Decrease of β-amyloid peptide precursor and ceruloplasmin mRNA levels in patients with Alzheimer’s disease support impairment of cellular iron efflux in this pathology

This research was supported by the Fundação para a Ciência e a Tecnologia (FCT) [SFRH/BPD/29354/2006 to MM, SFRH/BD/60718/2009 to BS, and SFRH/BD/48671/2008 to LM]; Fundação Astrazeneca (Research Grant awarded through the “Programme of Support to Research”); Instituto Nacional de Saúde Dr. Ricardo J...

ver descrição completa

Detalhes bibliográficos
Autor principal: Silva, Bruno (author)
Outros Autores: Guerreiro, Cláudia (author), C. Crespo, Ângela (author), Marques, Liliana (author), Marcelino, Erica (author), Maruta, Carolina (author), Costa, Sónia (author), Timóteo, Ângela (author), Vilares, Arminda (author), Simões Couto, Frederico (author), Faustino, Paula (author), Verdelho, Ana (author), Guerreiro, Manuela (author), Herrero, Ana (author), Costa, Cristina (author), de Mendonça, Alexandre (author), Martins, Madalena (author), Costa, Luciana (author)
Formato: conferenceObject
Idioma:eng
Publicado em: 2015
Assuntos:
Determinantes Imunológicos em Doenças Crónicas
Alzheimer’s disease
Iron Metabolism
Texto completo:http://hdl.handle.net/10400.18/2886
País:Portugal
Oai:oai:repositorio.insa.pt:10400.18/2886

Texto Completo

http://hdl.handle.net/10400.18/2886

Registos relacionados